SUNNYVALE, Calif.--(BUSINESS WIRE)--March 22, 2006--BARRX Medical, Inc. today announced that on March 16, 2006, the Company entered into an assignment and license agreement with Curon Medical Inc. (Nasdaq: CURN) for the assignment of United States Patent No. 6,872,206 and a worldwide exclusive license of certain patents for the treatment of Barrett's esophagus. This transaction strengthens BARRX Medical's strong intellectual property position within the field of Barrett's esophagus and allows the company to expand applications of the technology outside of this disease state. BARRX Medical, Inc. has paid Curon Medical Inc. $2.0 million in cash and $1.0 million in the form of a note payable by December 31, 2006.
